{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:06:38Z","timestamp":1790197598669,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["TEC2015-69076-P"],"award-info":[{"award-number":["TEC2015-69076-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2015-64146-R"],"award-info":[{"award-number":["SAF2015-64146-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["CD14\/00109"],"award-info":[{"award-number":["CD14\/00109"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CB07\/08\/0003"],"award-info":[{"award-number":["CB07\/08\/0003"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","award":["CB16\/11\/00403"],"award-info":[{"award-number":["CB16\/11\/00403"]}],"id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00627"],"award-info":[{"award-number":["PI15\/00627"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01729"],"award-info":[{"award-number":["PI14\/01729"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012513","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Cardiovasculares","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.metabol.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T12:01:32Z","timestamp":1555329692000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes"],"prefix":"10.1016","volume":"96","author":[{"given":"Ricardo","family":"Rodr\u00edguez-Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Girona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Samino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"de Gonzalo-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guaita-Esteruelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger W.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildo J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Yanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Correig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicenta","family":"Llorente-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"V\u00e1zquez-Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Masana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2019.04.007_bb0005","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1161\/CIRCULATIONAHA.111.077602","article-title":"Ectopic fat depots and cardiovascular disease","volume":"124","author":"Britton","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.04.007_bb0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.hfc.2013.10.002","article-title":"The role of coronary artery disease in heart failure","volume":"10","author":"Lala","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.metabol.2019.04.007_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1479164109338774","article-title":"Review article: left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease\u2014do we need to screen our patients?","volume":"6","author":"Roberts","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.metabol.2019.04.007_bb0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cardfail.2008.04.001","article-title":"Heart failure and diabetes mellitus: epidemiology and management of an alarming association","volume":"14","author":"Cohen-Solal","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.metabol.2019.04.007_bb0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.04.007_bb0030","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.04.007_bb0035","doi-asserted-by":"crossref","first-page":"R1202","DOI":"10.1152\/ajpregu.90820.2008","article-title":"Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats","volume":"297","author":"Bonen","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nm0410-400","article-title":"Diacylglycerol-mediated insulin resistance","volume":"16","author":"Erion","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2019.04.007_bb0045","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1096\/fj.04-2263com","article-title":"Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart","volume":"18","author":"Sharma","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2019.04.007_bb0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/db15-0627","article-title":"Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes","volume":"65","author":"Levelt","year":"2016","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.04.007_bb0055","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.04.007_bb0060","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1161\/CIRCULATIONAHA.110.955542","article-title":"Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus","volume":"122","author":"Ng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.04.007_bb0065","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0070","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1530\/JOE-17-0031","article-title":"Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease","volume":"233","author":"Rodriguez-Calvo","year":"2017","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0005-2760(97)00205-1","article-title":"Physiological properties and functions of intracellular fatty acid-binding proteins","volume":"1391","author":"Coe","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2019.04.007_bb0080","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00018-002-8490-y","article-title":"New insights into the structure and function of fatty acid-binding proteins","volume":"59","author":"Zimmerman","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.metabol.2019.04.007_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2019.04.007_bb0090","article-title":"Lipid chaperones and metabolic inflammation","volume":"2011","author":"Furuhashi","year":"2011","journal-title":"Int J Inflamm"},{"key":"10.1016\/j.metabol.2019.04.007_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-012-2737-4","article-title":"Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?","volume":"56","author":"Kralisch","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2019.04.007_bb0100","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2337\/dc07-0413","article-title":"Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort","volume":"30","author":"Tso","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2019.04.007_bb0105","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","article-title":"Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study","volume":"115","author":"Xu","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2019.04.007_bb0110","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/j.atherosclerosis.2007.04.045","article-title":"Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients","volume":"195","author":"Cabre","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2019.04.007_bb0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-014-0126-7","article-title":"Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population","volume":"13","author":"Fuseya","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0120","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1038\/nutd.2014.3","article-title":"Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects","volume":"4","author":"Baessler","year":"2014","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.metabol.2019.04.007_bb0125","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2310\/JIM.0b013e31826868f2","article-title":"Serum levels of adipocyte fatty acid-binding protein are independently associated with left ventricular mass and myocardial performance index in obstructive sleep apnea syndrome","volume":"60","author":"Balci","year":"2012","journal-title":"J Invest Med"},{"key":"10.1016\/j.metabol.2019.04.007_bb0130","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/heartjnl-2013-303735","article-title":"Fatty acid binding protein 4 predicts left ventricular mass and longitudinal function in overweight and obese women","volume":"99","author":"Engeli","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.metabol.2019.04.007_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1475-2840-12-105","article-title":"Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease","volume":"12","author":"Huang","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/CS20120004","article-title":"Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure","volume":"124","author":"Liu","year":"2013","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2019.04.007_bb0145","first-page":"e99","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure","volume":"116","author":"Tang","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.04.007_bb0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2840-12-72","article-title":"Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients","volume":"12","author":"Cabre","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurjhf\/hfs196","article-title":"Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study","volume":"15","author":"Djousse","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2019.04.007_bb0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.carpath.2008.02.006","article-title":"Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome","volume":"17","author":"Vural","year":"2008","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0165","article-title":"Cardiomyocyte overexpression of FABP4 aggravates pressure overload-induced heart hypertrophy","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2019.04.007_bb0170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/CS20150073","article-title":"Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia\/reperfusion injury and diabetes-induced cardiac dysfunction","volume":"129","author":"Zhou","year":"2015","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2019.04.007_bb0175","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.109.200501","article-title":"Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease","volume":"105","author":"Lamounier-Zepter","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2019.04.007_bb0180","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/ATVBAHA.113.301588","article-title":"Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle","volume":"33","author":"Iso","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0185","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/CIRCULATIONAHA.108.803916","article-title":"Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus","volume":"119","author":"van der Meer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2019.04.007_bb0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41598-017-00070-6","article-title":"Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes","volume":"7","author":"de Gonzalo-Calvo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2019.04.007_bb0195","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jacc.2004.12.051","article-title":"Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement","volume":"45","author":"Paelinck","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0200","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2337\/db07-0768","article-title":"Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects","volume":"56","author":"van der Meer","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2019.04.007_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/jmre.1997.1244","article-title":"Improved method for accurate and efficient quantification of MRS data with use of prior knowledge","volume":"129","author":"Vanhamme","year":"1997","journal-title":"J Magn Reson"},{"key":"10.1016\/j.metabol.2019.04.007_bb0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1148\/radiol.2451061904","article-title":"Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers","volume":"245","author":"van der Meer","year":"2007","journal-title":"Radiology."},{"key":"10.1016\/j.metabol.2019.04.007_bb0215","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/10976640601093703","article-title":"Magnetic resonance assessment of aortic pulse wave velocity, aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus","volume":"9","author":"van der Meer","year":"2007","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.metabol.2019.04.007_bb0220","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature05844","article-title":"Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2","volume":"447","author":"Furuhashi","year":"2007","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2019.04.007_bb0225","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2019.04.007_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/785783","article-title":"AICAR protects against high palmitate\/high insulin-induced intramyocellular lipid accumulation and insulin resistance in HL-1 cardiac cells by inducing PPAR-target gene expression","volume":"2015","author":"Rodriguez-Calvo","year":"2015","journal-title":"PPAR Res"},{"key":"10.1016\/j.metabol.2019.04.007_bb0235","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbalip.2017.02.006","article-title":"Small heterodimer partner (SHP) contributes to insulin resistance in cardiomyocytes","volume":"1862","author":"Rodriguez-Calvo","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2019.04.007_bb0240","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","article-title":"Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease","volume":"8","author":"Mehlem","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.metabol.2019.04.007_bb0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2016.04.012","article-title":"Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells","volume":"249","author":"Bosquet","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2019.04.007_bb0250","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac051437y","article-title":"XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification","volume":"78","author":"Smith","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.metabol.2019.04.007_bb0255","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/metabo2040775","article-title":"A guideline to univariate statistical analysis for LC\/MS-based untargeted metabolomics-derived data","volume":"2","author":"Vinaixa","year":"2012","journal-title":"Metabolites"},{"key":"10.1016\/j.metabol.2019.04.007_bb0260","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/hmg\/ddt042","article-title":"Over-expression of neuron-derived orphan receptor-1 (NOR-1) exacerbates neointimal hyperplasia after vascular injury","volume":"22","author":"Rodriguez-Calvo","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2019.04.007_bb0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2014.12.015","article-title":"NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFkappaB activation","volume":"80","author":"Calvayrac","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0270","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s00018-002-8474-y","article-title":"P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells","volume":"59","author":"Glass","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.metabol.2019.04.007_bb0275","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2004-1560","article-title":"Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells","volume":"146","author":"Jove","year":"2005","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2019.04.007_bb0280","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2009-1441","article-title":"Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus","volume":"95","author":"Jonker","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.04.007_bb0285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.numecd.2015.11.002","article-title":"Biomarkers and prediction of myocardial triglyceride content in non-diabetic men","volume":"26","author":"Graner","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2019.04.007_bb0290","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1016\/j.bbamcr.2015.09.002","article-title":"New insights into circulating FABP4: interaction with cytokeratin 1 on endothelial cell membranes","volume":"1853","author":"Saavedra","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2019.04.007_bb0295","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11906-005-0035-y","article-title":"Lipotoxicity in the heart","volume":"7","author":"Borradaile","year":"2005","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.metabol.2019.04.007_bb0300","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.04.007_bb0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2840-11-72","article-title":"Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells","volume":"11","author":"Aragones","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2019.04.007_bb0310","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbalip.2018.03.004","article-title":"FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation","volume":"1863","author":"Bosquet","year":"2018","journal-title":"Biochim Biophys Acta"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:21:44Z","timestamp":1777429304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049519300733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":62,"alternative-id":["S0026049519300733"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2019.04.007","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}